TherapyNotes, LLC – Trademark Portfolio
Entity Type: 16
TherapyNotes, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include THERAPYFUEL, THERAPYNOTES, and THERAPY NOTES. The owner is based in Horsham, PA.
630 Dresher Road
Horsham, PA 19044
Showing of trademarks Trademarks
Trademark Classifications
TherapyNotes, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does TherapyNotes, LLC have?
TherapyNotes, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 2 abandoned.
What trademark classes does TherapyNotes, LLC file in?
TherapyNotes, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 32 (Light Beverages). Class 42 covers scientific and technological services; industrial analysis and research services.
What are TherapyNotes, LLC's most well-known trademarks?
TherapyNotes, LLC's registered trademark portfolio includes well-known marks such as THERAPYFUEL, THERAPYNOTES, and THERAPY NOTES. These are among 3 currently registered trademarks in the portfolio.
What is TherapyNotes, LLC's trademark registration success rate?
TherapyNotes, LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 2 applications are pending review.